2nd Quarter - Report
340B HEALTH for 340B HEALTH
Firm
Client
Income
—
Expenses
$208,756
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
HR 2606 and S 1376. Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| DHRUBAJYOTI BHATTACHARYA | (No longer with organization) |
| MARISA SCHRADER CONWAY | — |
| ANNA MANGUM | LA for Rep. Viscloskey and Fascell 1988-91 |
| ROBERT RECKLAUS | Chief of Staff for Rep. Carolyn McCarthy 02-08 |
| TED SLAFSKY | Fellow for Sen. Democratic Policy Comm 1994 |
| JAIMIE VICKERY New | LA for Reps Horn and Biggert 2000-2005 |
| WILLIAM VON OEHSEN | — |
| BONNIE WEINTRAUB New | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.